Gut Inflammation Capsules are a research formulation combining BPC-157, KPV, PEA, and Tributyrin—four compounds widely studied for their roles in gastrointestinal integrity, inflammatory signaling, and gut barrier regulation. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, KPV is a tripeptide fragment of α-MSH, PEA (palmitoylethanolamide) is a naturally occurring fatty acid amide, and Tributyrin is a prodrug of butyric acid. Together, this capsule formulation is designed strictly for controlled laboratory research applications focused on gut health mechanisms.
Prior to the study of these targeted compounds, gastrointestinal inflammation research relied largely on broad anti-inflammatory agents and nonspecific interventions. Preclinical research has demonstrated that BPC-157 may influence angiogenesis, epithelial repair, and gut barrier stability, while KPV has been studied for its role in modulating inflammatory cytokine signaling. PEA has shown relevance in inflammation and immune response regulation, and Tributyrin serves as a butyrate source studied for its effects on intestinal epithelial energy metabolism and mucosal integrity. These complementary mechanisms have made this combination a notable subject in gastrointestinal research models.
Currently, Gut Inflammation Capsules are being investigated for their potential role in studies involving intestinal inflammation models, gut barrier dysfunction, microbiome-related signaling, and epithelial repair pathways. Additional research is exploring their influence on immune modulation, oxidative stress response, and inflammatory signaling within the gastrointestinal tract. As research continues, this formulation remains a compelling subject for ongoing laboratory investigation into gut health and inflammation-related mechanisms.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Gut Inflammation Capsules are a research formulation combining BPC-157, KPV, PEA, and Tributyrin—four compounds widely studied for their roles in gastrointestinal integrity, inflammatory signaling, and gut barrier regulation. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, KPV is a tripeptide fragment of α-MSH, PEA (palmitoylethanolamide) is a naturally occurring fatty acid amide, and Tributyrin is a prodrug of butyric acid. Together, this capsule formulation is designed strictly for controlled laboratory research applications focused on gut health mechanisms.
In practice, gut-focused research programs typically separate “barrier integrity” hypotheses from broader systemic variables by controlling diet composition, sampling cadence, stress exposure, and circadian timing. This blend is positioned for investigators who want a consolidated research input for studying GI integrity signaling while maintaining clean attribution inside a defined experimental lane.
Gut Inflammation Capsules – Research Specifications:
| Format | Encapsulated research formulation |
| Formula | BPC-157 + KPV + PEA + Tributyrin |
| Delivery Form | Capsules (research format) |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific analytical documentation |
| Appearance | Capsule format |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture |
| Research Use Only | Supplied exclusively for laboratory research use. Not for human consumption or clinical use. |
Gut inflammation research typically centers on three core domains: barrier integrity, immune-adjacent signaling, and microbiome-driven metabolite interactions. This formulation is built around four widely discussed research inputs that appear frequently across those domains, enabling investigators to study directional shifts in gut-related readouts with a consolidated, capsule-based format.
BPC-157 is often referenced in gastrointestinal integrity research because it is a stable gastric peptide associated with mucosal and tissue-repair signaling in experimental settings. KPV, a fragment of α-MSH, is commonly discussed in inflammatory signaling models. PEA is explored as an endogenous lipid mediator in immune and inflammation-adjacent research, and Tributyrin is studied as a butyrate prodrug that may support research into short-chain fatty acid dynamics relevant to gut barrier function.
For researchers who want to explore the individual components in a separate lane, Nordsci offers related research products such as BPC 157. In gut-focused experimental portfolios, isolating single-variable inputs can be helpful when teams want maximum interpretability across cohorts.
Important Research Notice: Nordsci research materials are supported by lot-specific analytical documentation. Certificates of Analysis are available for laboratory verification and reproducibility support.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
Many research programs evaluate gut barrier behavior through marker panels associated with epithelial integrity and permeability-adjacent dynamics. This formulation is positioned for investigators studying barrier-centric hypotheses where consistent diet control, timing, and stress management are required to reduce noise in readouts.
Inflammatory signaling research often examines cytokine behavior, immune mediator dynamics, and localized tissue responses under controlled conditions. With KPV and PEA included in the blend, researchers may design studies focused on inflammatory signal directionality and related GI marker shifts across standardized sampling windows.
Tributyrin is frequently discussed in research frameworks exploring butyrate availability and SCFA-related signaling. In gut health studies, SCFA pathways are often evaluated alongside microbiome composition variables and dietary fiber inputs to clarify metabolite-driven outcomes.
Some laboratories run blended formulations in parallel with single-compound lanes to evaluate whether directional shifts in endpoints are robust across different input strategies. When using blends, disciplined documentation, standardized sampling, and tight environment controls help protect interpretability and downstream decision-making.
Gut Inflammation Capsules should be handled according to standard laboratory SOPs for encapsulated research materials. Maintain storage integrity, keep containers sealed between uses, and document lot numbers and handling steps for traceability.
Protocol Design Considerations: Gut research endpoints can be sensitive to dietary variability, hydration status, sleep disruption, stress exposure, antibiotic history, and circadian timing. Tight controls and consistent sampling cadence substantially improve data quality.
Note: The information above is provided as a high-level research reference only. All experimental use must be conducted by qualified personnel in appropriately equipped facilities, following applicable regulations and institutional policies.
Each lot of Gut Inflammation Capsules is supported by a Certificate of Analysis documenting identity and quality parameters for the supplied research material. COAs support procurement workflows, internal QA, and reproducibility across study phases.
Laboratories sourcing gut-focused research materials typically prioritize transparent documentation, lot traceability, and consistent quality systems that support repeatable study execution. Nordsci Peptides supports documentation-driven procurement for research applications where reproducibility and method alignment are non-negotiable.
IMPORTANT: Gut Inflammation Capsules are supplied exclusively for laboratory research use. Not approved for human consumption or therapeutic use. Researchers are responsible for compliance with all applicable laws, regulations, and institutional guidelines.
